Plant-made oral vaccines against human infectious diseases-Are we there yet?

Plant Biotechnology Journal

Volumn 13, Issue 8, 2015, Pages 1056-1070

  Chan, Hui Ting ^a   Daniell, Henry ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioencapsulation; Human infectious diseases; Molecular farming; Mucosal immune response; Oral delivery; Plant transformation

Indexed keywords

VACCINE;

COMMUNICABLE DISEASES; GENETIC TRANSFORMATION; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; ORAL DRUG ADMINISTRATION; PLANT;

ADMINISTRATION, ORAL; COMMUNICABLE DISEASES; HUMANS; IMMUNITY; PLANTS; TRANSFORMATION, GENETIC; VACCINES;

EID: 84942199558     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/pbi.12471     Document Type: Review

References (126)

1. Adeniji, J.A. and Faleye, T.O. (2015) Enterovirus C strains circulating in Nigeria and their contribution to the emergence of recombinant circulating vaccine-derived polioviruses. Arch. Virol. 160, 675-683.
2. Ahmad, P., Ashraf, M., Younis, M., Hu, X., Kumar, A., Akram, N.A. and Al-Qurainy, F. (2012) Role of transgenic plants in agriculture and biopharming. Biotechnol. Adv. 30, 524-540.
3. Albarracín, R.M., Becher, M.L., Farran, I., Sander, V.A., Corigliano, M.G., Yácono, M.L., Pariani, S., Sánchez López, E., Veramendi, J. and Clemente, M. (2015) The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83-kDa improves expression levels in tobacco chloroplasts. Biotechnol. J. 10, 748-759.
4. Arcalis, E., Stadlmann, J., Rademacher, T., Marcel, S., Sack, M., Altmann, F. and Stoger, E. (2013) Plant species and organ influence the structure and subcellular localization of recombinant glycoproteins. Plant Mol. Biol. 83, 105-117.
5. Arlen, P.A., Falconer, R., Cherukumilli, S., Cole, A., Cole, A.M., Oishi, K.K. and Daniell, H. (2007) Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J. 5, 511-525.
6. Azegami, T., Yuki, Y. and Kiyono, H. (2014) Challenges in mucosal vaccines for the control of infectious diseases. Int. Immunol. 26, 517-528.
7. Azizi, A., Kumar, A., Diaz-Mitoma, F. and Mestecky, J. (2010) Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog. 6, e1001147.
8. Boes, A., Spiegel, H., Edgue, G., Kapelski, S., Scheuermayer, M., Fendel, R., Remarque, E., Altmann, F., Maresch, D., Reimann, A., Pradel, G., Schillberg, S. and Fischer, R. (2015) Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidate PfAMA1 produced in Nicotiana benthamiana and analysis of growth inhibitory responses in rabbits. Plant Biotechnol. J. 13, 222-234.
9. Böhles, N., Busch, K. and Hensel, M. (2014) Vaccines against human diarrheal pathogens: current status and perspectives. Hum. Vaccin. Immunother. 10, 1522-1535.
10. Boyhan, D. and Daniell, H. (2011) Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol. J. 9, 585-598.
11. Burns, C.C., Shaw, J., Jorba, J., Bukbuk, D., Adu, F., Gumede, N., Pate, M.A., Abanida, E.A., Gasasira, A., Iber, J., Chen, Q., Vincent, A., Chenoweth, P., Henderson, E., Wannemuehler, K., Naeem, A., Umami, R.N., Nishimura, Y., Shimizu, H., Baba, M., Adeniji, A., Williams, A.J., Kilpatrick, D.R., Oberste, M.S., Wassilak, S.G., Tomori, O., Pallansch, M.A. and Kew, O. (2013) Multiple independent emergences of Type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J. Virol. 87, 4907-4922.
12. Burns, C.C., Diop, O.M., Sutter, R.W. and Kew, O.M. (2014) Vaccine-derived polioviruses. J. Infect. Dis. 210(Suppl. 1), S283-S293.
13. Caroca, R., Howell, K.A., Hasse, C., Ruf, S. and Bock, R. (2013) Design of chimeric expression elements that confer high-level gene activity in chromoplasts. Plant J. 73, 368-379.
14. Chia, M.Y., Hsiao, S.H., Chan, H.T., Do, Y.Y., Huang, P.L., Chang, H.W., Tsai, Y.C., Lin, C.M., Pang, V.F. and Jeng, C.R. (2011) Evaluation of the immunogenicity of a transgenic tobacco plant expressing the recombinant fusion protein of GP5 of porcine reproductive and respiratory syndrome virus and B subunit of Escherichia coli heat-labile enterotoxin in pigs. Vet. Immunol. Immunopathol. 140, 215-225.
15. Clarke, J.L. and Daniell, H. (2011) Plastid biotechnology for crop production: present status and future perspectives. Plant Mol. Biol. 76, 211-220.
16. Cummings, J.F., Guerrero, M.L., Moon, J.E., Waterman, P., Nielsen, R.K., Jefferson, S., Gross, F.L., Hancock, K., Katz, J.M. and Yusibov, V. (2014) Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine, 32, 2251-2259.
17. Czerkinsky, C. and Holmgren, J. (2010) Topical immunization strategies. Mucosal Immunol. 3, 545-555.
18. Czyz, M., Dembczyński, R., Marecik, R., Wojas-Turek, J., Milczarek, M., Pajtasz-Piasecka, E., Wietrzyk, J. and Pniewski, T. (2014) Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B. Biomed. Res. Int. 2014, 485689.
19. Daniell, H. (2002) Molecular strategies for gene containment in transgenic crops. Nat. Biotechnol. 20, 581-586.
20. Daniell, H. (2007) Transgene containment by maternal inheritance: effective or elusive? Proc. Natl Acad. Sci. USA, 104, 6879-6880.
21. Daniell, H., Lee, S.B., Panchal, T. and Wiebe, P.O. (2001) Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 311, 1001-1009.
22. Daniell, H., Singh, N.D., Mason, H. and Streatfield, S.J. (2009) Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 14, 669-679.
23. Davitt, C.J. and Lavelle, E.C. (2015) Delivery strategies to enhance oral vaccination against enteric infections. Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2015.03.007.
24. Davoodi-Semiromi, A., Schreiber, M., Nalapalli, S., Verma, D., Singh, N.D., Banks, R.K., Chakrabarti, D. and Daniell, H. (2010) Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnol. J. 8, 223-242.
25. De Cosa, B., Moar, W., Lee, S.B., Miller, M. and Daniell, H. (2001) Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat. Biotechnol. 19, 71-74.
26. Del L. Yácono, M., Farran, I., Becher, M.L., Sander, V., Sánchez, V.R., Martín, V., Veramendi, J. and Clemente, M. (2012) A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice. Plant Biotechnol. J., 10, 1136-1144.
27. Egelkrout, E., Rajan, V. and Howard, J.A. (2012) Overproduction of recombinant proteins in plants. Plant Sci. 184, 83-101.
28. Eisenbarth, S.C., Williams, A., Colegio, O.R., Meng, H., Strowig, T., Rongvaux, A., Henao-Mejia, J., Thaiss, C.A., Joly, S., Gonzalez, D.G., Xu, L., Zenewicz, L.A., Haberman, A.M., Elinav, E., Kleinstein, S.H., Sutterwala, F.S. and Flavell, R.A. (2012) NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature, 484, 510-513.
29. Famulare, M. and Hu, H. (2015) Extracting transmission networks from phylogeographic data for epidemic and endemic diseases: Ebola virus in Sierra Leone, 2009 H1N1 pandemic influenza and polio in Nigeria. Int. Health, 7, 130-138.
30. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136, E359-E386.
31. Fernández-San Millán, A., Ortigosa, S.M., Hervás-Stubbs, S., Corral-Martínez, P., Seguí-Simarro, J.M., Gaétan, J., Coursaget, P. and Veramendi, J. (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol. J. 6, 427-441.
32. Flint, H.J., Bayer, E.A., Rincon, M.T., Lamed, R. and White, B.A. (2008) Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat. Rev. Microbiol. 6, 121-131.
33. Floss, D.M., Mockey, M., Zanello, G., Brosson, D., Diogon, M., Frutos, R., Bruel, T., Rodrigues, V., Garzon, E., Chevaleyre, C., Berri, M., Salmon, H., Conrad, U. and Dedieu, L. (2010) Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy. J. Biomed. Biotechnol. 2010, 274346.
34. Garcia, H.H., Rodriguez, S., Friedland, J.S. and Cysticercosis Working Group in Peru (2014) Immunology of Taenia solium taeniasis and human cysticercosis. Parasite Immunol., 36, 388-396.
35. Gomord, V., Fitchette, A.C., Menu-Bouaouiche, L., Saint-Jore-Dupas, C., Plasson, C., Michaud, D. and Faye, L. (2010) Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol. J. 8, 564-587.
36. Gonzalez-Rabade, N., McGowan, E.G., Zhou, F., McCabe, M.S., Bock, R., Dix, P.J., Gray, J.C. and Ma, J.K. (2011) Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice. Plant Biotechnol. J. 9, 629-638.
37. Govea-Alonso, D.O., Rubio-Infante, N., García-Hernández, A.L., Varona-Santos, J.T., Korban, S.S., Moreno-Fierros, L. and Rosales-Mendoza, S. (2013) Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta, 238, 785-792.
38. Gregory, J.A. and Mayfield, S.P. (2014) Developing inexpensive malaria vaccines from plants and algae. Appl. Microbiol. Biotechnol. 98, 1983-1990.
39. Guetard, D., Greco, R., Cervantes Gonzalez, M., Celli, S., Kostrzak, A., Langlade-Demoyen, P., Sala, F., Wain-Hobson, S. and Sala, M. (2008) Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration. Vaccine, 26, 4477-4485.
40. Guo, H.M., Gao, J.M., Luo, Y.L., Wen, Y.Z., Zhang, Y.L., Hide, G., Zhou, W.L., Ayala, F.J. and Lun, Z.R. (2015) Infection by Toxoplasma gondii, a severe parasite in neonates and AIDS patients, causes impaired anion secretion in airway epithelia. Proc. Natl Acad. Sci. USA, 112, 4435-4440.
41. Haq, T.A., Mason, H.S., Clements, J.D. and Arntzen, C.J. (1995) Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science, 268, 714-716.
42. Hayden, C.A., Egelkrout, E.M., Moscoso, A.M., Enrique, C., Keener, T.K., Jimenez-Flores, R., Wong, J.C. and Howard, J.A. (2012a) Production of highly concentrated, heat-stable hepatitis B surface antigen in maize. Plant Biotechnol. J. 10, 979-984.
43. Hayden, C.A., Streatfield, S.J., Lamphear, B.J., Fake, G.M., Keener, T.K., Walker, J.H., Clements, J.D., Turner, D.D., Tizard, I.R. and Howard, J.A. (2012b) Bioencapsulation of the hepatitis B surface antigen and its use as an effective oral immunogen. Vaccine, 30, 2937-2942.
44. Hayden, C.A., Smith, E.M., Turner, D.D., Keener, T.K., Wong, J.C., Walker, J.H., Tizard, I.R., Jimenez-Flores, R. and Howard, J.A. (2014) Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen. Vaccine, 32, 1240-1246.
45. Hayden, C.A., Fischer, M.E., Andrews, B.L., Chilton, H.C., Turner, D.D., Walker, J.H., Tizard, I.R. and Howard, J.A. (2015) Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses. Vaccine, 33, 2881-2886.
46. Hede, M.S., Salimova, E., Piszczek, A., Perlas, E., Winn, N., Nastasi, T. and Rosenthal, N. (2012) E-peptides control bioavailability of IGF-1. PLoS ONE, 7, e51152.
47. Hefferon, K. (2013) Plant-derived pharmaceuticals for the developing world. Biotechnol. J. 8, 1193-1202.
48. Hermann, J.R., Fry, A.M., Siev, D., Slate, D., Lewis, C. and Gatewood, D.M. (2011) Stability of vaccinia-vectored recombinant oral rabies vaccine under field conditions: a 3-year study. Can. J. Vet. Res. 75, 278-284.
49. Hernández, M., Rosas, G., Cervantes, J., Fragoso, G., Rosales-Mendoza, S. and Sciutto, E. (2014) Transgenic plants: a 5-year update on oral antipathogen vaccine development. Expert Rev. Vaccines, 13, 1523-1536.
50. Hill, D.R., Ford, L. and Lalloo, D.G. (2006) Oral cholera vaccines: use in clinical practice. Lancet Infect. Dis. 6, 361-373.
51. Holásková, E., Galuszka, P., Frébort, I. and Öz, M.T. (2015) Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology. Biotechnol. Adv. doi:10.1016/j.biotechadv.2015.03.007.
52. Jones, R.M., Chichester, J.A., Mett, V., Jaje, J., Tottey, S., Manceva, S., Casta, L.J., Gibbs, S.K., Musiychuk, K., Shamloul, M., Norikane, J., Mett, V., Streatfield, S.J., van de Vegte-Bolmer, M., Roeffen, W., Sauerwein, R.W. and Yusibov, V. (2013) A plant-produced Pfs25 VLP malaria vaccine candidate induces persistent transmission blocking antibodies against Plasmodium falciparum in immunized mice. PLoS ONE, 8, e79538.
53. Kanagaraj, A.P., Verma, D. and Daniell, H. (2011) Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol. Biol. 76, 323-333.
54. Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A. and Legocki, A.B. (1999) A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13, 1796-1799.
55. Karaman, S., Cunnick, J. and Wang, K. (2012) Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea. Plant Cell Rep. 31, 527-537.
56. Khan, I., Twyman, R.M., Arcalis, E. and Stoger, E. (2012) Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J. 7, 1099-1108.
57. Kim, T.G., Kim, B.G., Kim, M.Y., Choi, J.K., Jung, E.S. and Yang, M.S. (2010) Expression and immunogenicity of enterotoxigenic Escherichia coli heat-labile toxin B subunit in transgenic rice callus. Mol. Biotechnol. 44, 14-21.
58. Kohli, N., Westerveld, D.R., Ayache, A.C., Verma, A., Shil, P., Prasad, T., Zhu, P., Chan, S.L., Li, Q. and Daniell, H. (2014) Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers. Mol. Ther. 22, 535-546.
59. Kumar, S., Hahn, F.M., Baidoo, E., Kahlon, T.S., Wood, D.F., McMahan, C.M., Cornish, K., Keasling, J.D., Daniell, H. and Whalen, M.C. (2012) Remodeling the isoprenoid pathway in tobacco by expressing the cytoplasmic mevalonate pathway in chloroplasts. Metab. Eng. 14, 19-28.
60. Kwon, K.C., Nityanandam, R., New, J.S. and Daniell, H. (2013a) Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. Plant Biotechnol. J. 11, 77-86.
61. Kwon, K.C., Verma, D., Singh, N.D., Herzog, R. and Daniell, H. (2013b) Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Adv. Drug Deliv. Rev. 65, 782-799.
62. Lakshmi, P.S., Verma, D., Yang, X., Lloyd, B. and Daniell, H. (2013) Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro. PLoS ONE, 8, e54708.
63. Lamichhane, A., Azegamia, T. and Kiyonoa, H. (2014) The mucosal immune system for vaccine development. Vaccine, 32, 6711-6723.
64. Landry, N., Ward, B.J., Trepanier, S., Montomoli, E., Dargis, M., Lapini, G. and Vezina, L.-P. (2010) Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 Influenza. PLoS ONE, 5, e15559.
65. Le Mauff, F., Mercier, G., Chan, P., Burel, C., Vaudry, D., Bardor, M., Vézina, L., Couture, M., Lerouge, P. and Landry, N. (2014) Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants. Plant Biotechnol. J. 13, 717-725.
66. Lee, C., Kim, H.H., Choi, K.M., Chung, K.W., Choi, Y.K., Jang, M.J., Kim, T.S., Chung, N.J., Rhie, H.G., Lee, H.S., Sohn, Y., Kim, H., Lee, S.J. and Lee, H.W. (2011) Murine immune responses to a Plasmodium vivax-derived chimeric recombinant protein expressed in Brassica napus. Malar. J. 10, 106.
67. Lee, G., Na, Y.J., Yang, B.G., Choi, J.P., Seo, Y.B., Hong, C.P., Yun, C.H., Kim, D.H., Sohn, E.J., Kim, J.H., Sung, Y.C., Kim, Y.K., Jang, M.H. and Hwang, I. (2015) Oral immunization of haemaggulutinin H5 expressed in plant endoplasmic reticulum with adjuvant saponin protects mice against highly pathogenic avian influenza A virus infection. Plant Biotechnol. J. 13, 62-72.
68. Lico, C., Santi, L., Twyman, R.M., Pezzotti, M. and Avesani, L. (2012) The use of plants for the production of therapeutic human peptides. Plant Cell Rep. 31, 439-451.
69. Limaye, A., Koya, V., Samsam, M. and Daniell, H. (2006) Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 20, 959-961.
70. Lindh, I., Bråve, A., Hallengärd, D., Hadad, R., Kalbina, I., Strid, A. and Andersson, S. (2014) Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses. Vaccine, 32, 2288-2293.
71. Liu, H., Li, X., Lei, T., Li, W., Si, L. and Zheng, J. (2013) Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice. Hum. Vaccin. Immunother. 9, 83-89.
72. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S.Y., AlMazroa, M.A., Alvarado, M., Anderson, H.R., Anderson, L.M., Andrews, K.G., Atkinson, C., Baddour, L.M., Barker-Collo, S., Bartels, D.H., Bell, M.L., Benjamin, E.J., Bennett, D., Bhalla, K., Bikbov, B., Bin Abdulhak, A., Birbeck, G., Blyth, F., Bolliger, I., Boufous, S., Bucello, C., Burch, M., Burney, P., Carapetis, J., Chen, H., Chou, D., Chugh, S.S., Coffeng, L.E., Colan, S.D., Colquhoun, S., Colson, K.E., Condon, J., Connor, M.D., Cooper, L.T., Corriere, M., Cortinovis, M., de Vaccaro, K.C., Couser, W., Cowie, B.C., Criqui, M.H., Cross, M., Dabhadkar, K.C., Dahodwala, N., De Leo, D., Degenhardt, L., Delossantos, A., Denenberg, J., Des Jarlais, D.C., Dharmaratne, S.D., Dorsey, E.R., Driscoll, T., Duber, H., Ebel, B., Erwin, P.J., Espindola, P., Ezzati, M., Feigin, V., Flaxman, A.D., Forouzanfar, M.H., Fowkes, F.G., Franklin, R., Fransen, M., Freeman, M.K., Gabriel, S.E., Gakidou, E., Gaspari, F., Gillum, R.F., Gonzalez-Medina, D., Halasa, Y.A., Haring, D., Harrison, J.E., Havmoeller, R., Hay, R.J., Hoen, B., Hotez, P.J., Hoy, D., Jacobsen, K.H., James, S.L., Jasrasaria, R., Jayaraman, S., Johns, N., Karthikeyan, G., Kassebaum, N., Keren, A., Khoo, J.P., Knowlton, L.M., Kobusingye, O., Koranteng, A., Krishnamurthi, R., Lipnick, M., Lipshultz, S.E., Ohno, S.L., Mabweijano, J., MacIntyre, M.F., Mallinger, L., March, L., Marks, G.B., Marks, R., Matsumori, A., Matzopoulos, R., Mayosi, B.M., McAnulty, J.H., McDermott, M.M., McGrath, J., Memish, Z.A., Mensah, G.A., Merriman, T.R., Michaud, C., Miller, M., Miller, T.R., Mock, C., Mocumbi, A.O., Mokdad, A.A., Moran, A., Mulholland, K., Nair, M.N., Naldi, L., Narayan, K.M., Nasseri, K., Norman, P., O'Donnell, M., Omer, S.B., Ortblad, K., Osborne, R., Ozgediz, D., Pahari, B., Pandian, J.D., Rivero, A.P., Padilla, R.P., Perez-Ruiz, F., Perico, N., Phillips, D., Pierce, K., Pope, C.A. III, Porrini, E., Pourmalek, F., Raju, M., Ranganathan, D., Rehm, J.T., Rein, D.B., Remuzzi, G., Rivara, F.P., Roberts, T., De León, F.R., Rosenfeld, L.C., Rushton, L., Sacco, R.L., Salomon, J.A., Sampson, U., Sanman, E., Schwebel, D.C., Segui-Gomez, M., Shepard, D.S., Singh, D., Singleton, J., Sliwa, K., Smith, E., Steer, A., Taylor, J.A., Thomas, B., Tleyjeh, I.M., Towbin, J.A., Truelsen, T., Undurraga, E.A., Venketasubramanian, N., Vijayakumar, L., Vos, T., Wagner, G.R., Wang, M., Wang, W., Watt, K., Weinstock, M.A., Weintraub, R., Wilkinson, J.D., Woolf, A.D., Wulf, S., Yeh, P.H., Yip, P., Zabetian, A., Zheng, Z.J., Lopez, A.D. and Murray, C.J. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-2128.
73. Loza-Rubio, E., Rojas-Anaya, E., López, J., Olivera-Flores, M.T., Gómez-Lim, M. and Tapia-Pérez, G. (2012) Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Vaccine, 30, 5551-5556.
74. Maldaner, F.R., Aragão, F.J., dos Santos, F.B., Franco, O.L., da Rocha Queiroz Lima, M., de Oliveira Resende, R., Vasques, R.M. and Nagata, T. (2013) Dengue virus tetra-epitope peptide expressed in lettuce chloroplasts for potential use in dengue diagnosis. Appl. Microbiol. Biotechnol., 97, 5721-5729.
75. Martens, E.C., Lowe, E.C., Chiang, H., Pudlo, N.A., Wu, M., McNulty, N.P., Abbott, D.W., Henrissat, B., Gilbert, H.J., Bolam, D.N. and Gordon, J.I. (2011) Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol. 9, e1001221.
76. Monreal-Escalante, E., Bañuelos-Hernández, B., Hernández, M., Fragoso, G., Garate, T., Sciutto, E. and Rosales-Mendoza, S. (2015) Expression of multiple Taenia Solium immunogens in plant cells through a ribosomal skip mechanism. Mol. Biotechnol. 57, 635-643.
77. Monroy-García, A., Gómez-Lim, M.A., Weiss-Steider, B., Hernández-Montes, J., Huerta-Yepez, S., Rangel-Santiago, J.F., Santiago-Osorio, E. and de Mora García, M.L. (2014) Immunization with an HPV-16 L1-based chimeric virus-like particle containing HPV-16 E6 and E7 epitopes elicits long-lasting prophylactic and therapeutic efficacy in an HPV-16 tumor mice model. Arch. Virol., 159, 291-305.
78. Nahampun, H.N., Bosworth, B., Cunnick, J., Mogler, M. and Wang, K. (2015) Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice. Plant Cell Rep. 34, 969-980.
79. Obembe, O.O., Popoola, J.O., Leelavathi, S. and Reddy, S.V. (2011) Advances in plant molecular farming. Biotechnol. Adv. 29, 210-222.
80. Oliveira, R.P., Santiago, A.F., Ficker, S.M., Gomes-Santos, A.C. and Faria, A.M. (2015) Antigen administration by continuous feeding enhances oral tolerance and leads to long-lasting effects. J. Immunol. Methods, 421, 36-43.
81. Parlog, A., Schlüter, D. and Dunay, I.R. (2015) Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 37, 159-170.
82. Pasetti, M.F., Simon, J.K., Sztein, M.B. and Levine, M.M. (2011) Immunology of gut mucosal vaccines. Immunol. Rev. 239, 125-148.
83. Peters, J. and Stoger, E. (2011) Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum. Vaccin. 7, 367-374.
84. Phan, H.T., Pohl, J., Floss, D.M., Rabenstein, F., Veits, J., Le, B.T., Chu, H.H., Hause, G., Mettenleiter, T. and Conrad, U. (2013) ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice. Plant Biotechnol. J. 11, 582-593.
85. Philippou, A. and Barton, E.R. (2014) Optimizing IGF-I for skeletal muscle therapeutics. Growth Horm. IGF Res. 24, 157-163.
86. Pniewski, T., Kapusta, J., Bociag, P., Wojciechowicz, J., Kostrzak, A., Gdula, M., Fedorowicz-Strońska, O., Wójcik, P., Otta, H., Samardakiewicz, S., Wolko, B. and Płucienniczak, A. (2011) Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J. Appl. Genet. 52, 125-136.
87. Rosales-Mendoza, S., Soria-Guerra, R.E., Moreno-Fierros, L., Govea-Alonso, D.O., Herrera-Díaz, A., Korban, S.S. and Alpuche-Solís, A.G. (2011) Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants. Plant Cell Rep. 30, 1145-1152.
88. Rosales-Mendoza, S., Rubio-Infante, N., Govea-Alonso, D.O. and Moreno-Fierros, L. (2012) Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV). Plant Cell Rep. 31, 495-511.
89. Rubio-Infante, N., Govea-Alonso, D.O., Alpuche-Solís, Á.G., García-Hernández, A.L., Soria-Guerra, R.E., Paz-Maldonado, L.M., Ilhuicatzi-Alvarado, D., Varona-Santos, J.T., Verdín-Terán, L., Korban, S.S., Moreno-Fierros, L. and Rosales-Mendoza, S. (2012) A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice. Plant Mol. Biol. 78, 337-349.
90. Rubio-Infante, N., Govea-Alonso, D.O., Romero-Maldonado, A., García-Hernández, A.L., Ilhuicatzi-Alvarado, D., Salazar-González, J.A., Korban, S.S., Rosales-Mendoza, S. and Moreno-Fierros, L. (2015) A plant-derived Multi-HIV antigen induces broad immune responses in orally immunized mice. Mol. Biotechnol. 57, 662-674.
91. Ruhlman, T., Ahangari, R., Devine, A., Samsam, M. and Daniell, H. (2007) Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol. J. 5, 495-510.
92. Ruhlman, T., Verma, D., Samson, N. and Daniell, H. (2010) The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant Physiol. 152, 2088-2104.
93. Sack, M., Hofbauer, A., Fischer, R. and Stoger, E. (2015) The increasing value of plant-made proteins. Curr. Opin. Biotechnol. 32, 163-170.
94. Sanz-Barrio, R., Millán, A.F., Corral-Martínez, P., Seguí-Simarro, J.M. and Farran, I. (2011) Tobacco plastidial thioredoxins as modulators of recombinant protein production in transgenic chloroplasts. Plant Biotechnol. J. 9, 639-650.
95. Scotti, N., Buonaguro, L., Tornesello, M.L., Cardi, T. and Buonaguro, F.M. (2010) Plant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches. Expert Rev. Vaccines, 9, 925-936.
96. Scotti, N., Rigano, M.M. and Cardi, T. (2012) Production of foreign proteins using plastid transformation. Biotechnol. Adv. 30, 387-397.
97. Shakhar, G., Lindquist, R.L., Skokos, D., Dudziak, D., Huang, J.H., Nussenzweig, M.C. and Dustin, M.L. (2005) Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat. Immunol. 6, 707-714.
98. Shenoy, V., Kwon, K.C., Rathinasabapathy, A., Lin, S., Jin, G., Song, C., Shil, P., Nair, A., Qi, Y., Li, Q., Francis, J., Katovich, M.J., Daniell, H. and Raizada, M.K. (2014) Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension. Hypertension, 64, 1248-1259.
99. Sherman, A., Su, J., Lin, S., Wang, X., Herzog, R.W. and Daniell, H. (2014) Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells. Blood, 124, 1659-1668.
100. Shil, P.K., Kwon, K.C., Zhu, P., Verma, A., Daniell, H. and Li, Q. (2014) Oral delivery of ACE2/Ang-(1-7) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis. Mol. Ther. 22, 2069-2082.
101. Shoji, Y., Chichester, J.A., Jones, M., Manceva, S.D., Damon, E., Mett, V., Musiychuk, K., Bi, H., Farrance, C., Shamloul, M., Kushnir, N., Sharma, S. and Yusibov, V. (2011) Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza. Hum. Vaccin., 7(Suppl.), 41-50.
102. Singh, A., Srivastava, S., Chouksey, A., Panwar, B.S., Verma, P.C., Roy, S., Singh, P.K., Saxena, G. and Tuli, R. (2015) Expression of rabies glycoprotein and ricin toxin B chain (RGP-RTB) fusion protein in tomato hairy roots: a step towards oral vaccination for rabies. Mol. Biotechnol. 57, 359-370.
103. Tacket, C.O., Mason, H.S., Losonsky, G., Clements, J.D., Levine, M.M. and Arntzen, C.J. (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4, 607-609.
104. Tacket, C.O., Mason, H.S., Losonsky, G., Estes, M.K., Levine, M.M. and Arntzen, C.J. (2000) Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. 182, 302-305.
105. Tacket, C.O., Pasetti, M.F., Edelman, R., Howard, J.A. and Streatfield, S. (2004) Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine, 22, 4385-4389.
106. Thanavala, Y. and Lugade, A.A. (2010) Oral transgenic plant-based vaccine for hepatitis B. Immunol. Res. 46, 4-11.
107. Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C.J. and Mason, H.S. (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc. Natl Acad. Sci. USA, 102, 3378-3382.
108. Tokuhara, D., Yuki, Y., Nochi, T., Kodama, T., Mejima, M., Kurokawa, S., Takahashi, Y., Nanno, M., Nakanishi, U., Takaiwa, F., Honda, T. and Kiyono, H. (2010) Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine. Proc. Natl Acad. Sci. USA, 107, 8794-8799.
109. Tremblay, R., Wang, D., Jevnikar, A.M. and Ma, S. (2010) Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol. Adv. 28, 214-221.
110. Uvarova, E.A., Belavin, P.A., Permyakova, N.V., Zagorskaya, A.A., Nosareva, O.V., Kakimzhanova, A.A. and Deineko, E.V. (2013) Oral Immunogenicity of plant-made Mycobacterium tuberculosis ESAT6 and CFP10. Biomed. Res. Int. 2013, 316304.
111. Verma, D., Moghimi, B., LoDuca, P.A., Singh, H.D., Hoffman, B.E., Herzog, R.W. and Daniell, H. (2010) Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc. Natl Acad. Sci. USA, 107, 7101-7106.
112. de Vries, R.P., Smit, C.H., de Bruin, E., Rigter, A., de Vries, E., Cornelissen, L.A., Eggink, D., Chung, N.P., Moore, J.P., Sanders, R.W., Hokke, C.H., Koopmans, M., Rottier, P.J. and de Haan, C.A. (2012) Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J. Virol. 86, 11735-11744.
113. Waheed, M.T., Thönes, N., Müller, M., Hassan, S.W., Gottschamel, J., Lössl, E., Kaul, H.P. and Lössl, A.G. (2011a) Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes. Plant Biotechnol. J. 9, 651-660.
114. Waheed, M.T., Thönes, N., Müller, M., Hassan, S.W., Razavi, N.M., Lössl, E., Kaul, H.P. and Lössl, A.G. (2011b) Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. Transgenic Res. 20, 271-282.
115. Waheed, M.T., Gottschamel, J., Hassan, S.W. and Lössl, A.G. (2012) Plant-derived vaccines: an approach for affordable vaccines against cervical cancer. Hum. Vaccin. Immunother. 8, 403-406.
116. +IgD-S. Typhi-specific IgA and IgG B memory cells in humans. Clin. Immunol. 138, 187-200.
117. Walsh, G. (2014) Biopharmaceutical benchmarks 2014. Nat. Biotechnol. 32, 992-1000.
118. Wang, X., Sherman, A., Liao, G., Leong, K.W., Daniell, H., Terhorst, C. and Herzog, R.W. (2013) Mechanism of oral tolerance induction to therapeutic proteins. Adv. Drug Deliv. Rev. 65, 759-773.
119. Wang, H.B., Fang, G., Yu, W.Z., Du, F., Fan, C.X., Liu, Q.L., Hao, L.X., Liu, Y., Zheng, J.S., Qin, Z.Y., Xia, W., Zhang, S.Y., Yin, Z.D., Jing, Q., Zhang, Y.X., Huang, R.N., Yang, R.P., Tong, W.B., Qi, Q., Guan, X.J., Jing, Y.L., Ma, Q.L., Wang, J., Ma, X.Z., Chen, N., Zheng, H.R., Li, Y.Q., Ma, C., Su, Q.R., Reilly, K.H., Luo, H.M., Wu, X.P., Wen, N. and Yang, W.Z. (2014) An outbreak of type II vaccine-derived poliovirus in sichuan province, China: emergence and circulation in an under-immunized population. PLoS ONE, 9, e113880.
120. + T cells. Blood, 125, 2418-2427.
121. WHO (2014a) Global tuberculosis report 2014. World Health Organization. Available: http://www.who.int/tb/publications/global_report/en/.
122. WHO (2014b) World Malaria Report 2014. World Health Organization. Available: http://www.who.int/malaria/publications/world_malaria_report_2014/report/en/
123. Youm, J.W., Won, Y.S., Jeon, J.H., Moon, K.B., Kim, H.C., Shin, K.S., Joung, H. and Kim, H.S. (2010) Antibody responses in mice stimulated by various doses of the potato-derived major surface antigen of hepatitis B virus. Clin. Vaccine Immunol. 17, 2029-2032.
124. Yuki, Y. and Kiyono, H. (2009) Mucosal vaccines: novel advances in technology and delivery. Expert Rev. Vaccines, 8, 1083-1097.
125. Yusibov, V., Streatfield, S.J. and Kushnir, N. (2011) Clinical development of plant-produced recombinant pharmaceuticals-Vaccines, antibodies and beyond. Hum. Vaccin. 7, 313-321.
126. Zinselmeyer, B.H., Dempster, J., Gurney, A.M., Wokosin, D., Miller, M., Ho, H., Millington, O.R., Smith, K.M., Rush, C.M., Parker, I., Cahalan, M., Brewer, J.M. and Garside, P. (2005) In situ characterization of CD4 + T-cell behaviour in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance. J. Exp. Med. 201, 1815-1823.